Profile
Elaine Waller worked as an Assistant Director-Clinical Research at Drug Dynamics Institute.
She then worked as Senior VP-Regulatory Affairs & Quality Assurance at Sonus Pharmaceuticals, Inc. from 2003 to 2008.
From 2008 to 2018, she worked as Executive Vice President-Regulatory Affairs at Seagen Inc. She also worked as Principal at Marion Merrell Dow, Inc. and The University of Texas at Austin.
Additionally, she worked as Vice President-North American Regulatory Affairs at Hoechst Marion Roussel, Inc. Dr. Waller holds an MBA from Rockhurst University and an undergraduate and doctorate degree from the University of Missouri-Kansas City.
Former positions of Elaine Waller
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | General Counsel | 01/05/2018 |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | General Counsel | 22/08/2008 |
| Drug Dynamics Institute | Corporate Officer/Principal | - |
| The University of Texas at Austin | Corporate Officer/Principal | - |
| Marion Merrell Dow, Inc. | Corporate Officer/Principal | - |
Training of Elaine Waller
| Rockhurst University | Masters Business Admin |
| University of Missouri-Kansas City | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
Radiant Research, Inc.
 Radiant Research, Inc. Miscellaneous Commercial ServicesCommercial Services Radiant Research, Inc. is engaged in the provision of clinical research services. It offers services to biopharmaceutical companies by conducting the clinical research protocol and collecting the data necessary to support the drug company's product to the FDA. The firm also provides consulting, regulatory expertise, study concept, protocol design, site selection, project, vendor management, clinical monitoring, medical monitoring, safety review, pharmacovigilance, data management, statistical analysis, reports and presentations. The company was founded in 1997 by Michael K. Lester and is headquartered in Cincinnati, OH. | Commercial Services |
| Hoechst Marion Roussel, Inc. | |
| Drug Dynamics Institute |
- Stock Market
- Insiders
- Elaine Waller
